Unknown

Dataset Information

0

Synthesis and Rational Design of New Appended 1,2,3-Triazole-uracil Ensembles as Promising Anti-Tumor Agents via In Silico VEGFR-2 Transferase Inhibition.


ABSTRACT: Angiogenesis inhibition is a key step towards the designing of new chemotherapeutic agents. In a view to preparing new molecular entities for cancer treatment, eighteen 1,2,3-triazole-uracil ensembles 5a-r were designed and synthesized via the click reaction. The ligands were well characterized using 1H-, 13C-NMR, elemental analysis and ESI-mass spectrometry. The in silico binding propinquities of the ligands were studied sequentially in the active region of VEGFR-2 using the Molegro virtual docker. All the compounds produced remarkable interactions and potentially inhibitory ligands against VEGFR-2 were obtained with high negative binding energies. Drug-likeness was assessed from the ADME properties. Cytotoxicity of the test compounds was measured against HeLa and HUH-7 tumor cells and NIH/3T3 normal cells by MTT assay. Compound 5h showed higher growth inhibition activity than the positive control, 5-fluorouracil (5-FU), against both HeLa and HUH-7 cells with IC50 values of 4.5 and 7.7 μM respectively. Interestingly, the compounds 5a-r did not show any cytotoxicity towards the normal cell lines. The results advance the position of substituted triazoles in the area of drug design with no ambiguity.

SUBMITTER: Reddy NN 

PROVIDER: S-EPMC8037033 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8482464 | biostudies-literature
| S-EPMC6222349 | biostudies-literature
| S-EPMC6930555 | biostudies-literature
| S-EPMC7344790 | biostudies-literature
| S-EPMC4924595 | biostudies-literature
| S-EPMC2968371 | biostudies-literature
| S-EPMC4924597 | biostudies-literature
| S-EPMC8469956 | biostudies-literature
| S-EPMC3448000 | biostudies-literature
| S-EPMC7327255 | biostudies-literature